## Background and Objective: We report two cases of hemangiomas in twins born at a gestational age of 30 weeks who were treated with a flashlamp-pumped pulsed dye laser (FPDL) at 40 days postpartem. These were the youngest patients to our knowledge to be treated with FPDL. Study Design/Patients an
Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas
β Scribed by Taro Kono; Hiroyuki Sakurai; William Frederick Groff; Henry H. Chan; Masaki Takeuchi; Takashi Yamaki; Kazutaka Soejima; Motohiro Nozaki
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 82 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background and Objective
The role of pulsed dye laser (PDL) in the treatment of childhood hemangiomas is still controversial because of the inherent characteristics of hemangiomas as well as the side effects of the PDL. Recently, the long pulsed dye laser (LPDL) with cryogen spray cooling (CSC) has been found relatively more effective and safer than the PDL in the treatment of portβwine stains and telangiectasia. This study was designed to compare the efficacy and complication rate of PDL versus LPDL for treating childhood hemangiomas.
Study Design/Materials and Methods
We did a prospective, randomized, controlled trial in which we enrolled 52 Asian infants, aged 1β3 months, with early hemangiomas. These infants were assigned to PDL treatment (nβ=β26) or LPDL treatment (nβ=β26) and followed to age 1 year. A PDL with a wavelength of 585 nm and spot size of 7 mm and a LPDL with a wavelength of 595 nm and spot size of 7 mm were used. Each patient in the PDL group was treated with energy fluence between 6 and 7 J/cm^2^ and a pulse duration of 0.45 milliseconds without epidermal cooling. Each patient in the LPDL group was treated with energy fluence between 9 and 15 J/cm^2^ and a pulse duration of 10β20 milliseconds, utilizing CSC to protect the epidermis. Each group was treated at 4βweek intervals until the lesion cleared. When each patient reached an age of 1 year, outcome measures such as clearance rate, time period of maximum proliferation, and complications were assessed.
Results
The number of children whose lesions showed complete clearance or minimal residual signs at 1 year of age was 14 (54%) in the PDL group and 17 (65%) in the LPDL group (Pβ=β0.397). Compared with the LPDL, PDL treated children had more hypopigmentation (3, 12% vs. 8, 31%; Pβ=β0.001), more hyperpigmentation (2, 8% vs. 4, 15%; Pβ=β0.005), and more textural changes (1, 4% vs. 6, 23%; Pβ=β0.001). The average time period of maximum proliferation in the LPDL group was significantly shorter than that of the PDL group (106 days vs. 177 days; Pβ=β0.01).
Conclusion
Early treatment of childhood hemangiomas with the LPDL is safer and more effective than the PDL. Lasers Surg. Med. 38:112β115, 2006. Β© 2005 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract ## Background and Objective Presenting the longβterm results of flashlampβpumped pulsed dye laser treatment in 617 hemangiomas to evaluate this treatment modality. ## Study Design/Materials and Methods In 548 children, 692 hemangiomas were treated with the flashlampβpumped pulsed dye
## Background and objectives: Laser-induced photo thermal damage has been combined with photodynamic therapy (pdt) using a systemic photosensitiser to treat vascular lesions. the efficacy of pdt using systemic 5-aminolaevulinic acid (5-ala) as the photosensitiser and pulsed dye laser (pdl) as the l
## Background and objective: Pulsed dye lasers (pdl) operating at 585 nm wavelength and 0.45 msec pulsewidth offer effective treatment for port wine stains (pws). vessels in leg telangiectasias are larger than those in pws. longer pulsewidths and wavelengths may improve clearance of these larger ve
## Abstract ## Introduction The pulsed dye laser (PDL) using varying fluences and pulse durations have been used to treat hemangiomas. This study aims to examine the efficacy and safety of the 595βnm PDL for the treatment of infantile hemangiomas using short (1.5β3 milliseconds) versus long (10 mi
## Abstract ## Background The 595βnm pulsed dye laser has been used for the treatment of benign epidermal pigmented lesions (EPLs), but there is a risk of inducing undesirable purpura with treatment. ## Objective To compare a 607βnm laser with a commerciallyβavailable 595βnm laser for the treatm